Exchange: OTC·Updated 12:03 PM EDT

CHMMF Chimeric Therapeutics Limited

$0.10
$2.90
(96.67%)
Today
Mkt Cap$81,100.00
Vol300.00

About CHMMF

Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.
50

Neutral Sentiment

How do you feel about CHMMF?

Advertisement|Remove ads.